We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
- Authors
Nath, Aritro; Cosgrove, Patrick A.; Mirsafian, Hoda; Christie, Elizabeth L.; Pflieger, Lance; Copeland, Benjamin; Majumdar, Sumana; Cristea, Mihaela C.; Han, Ernest S.; Lee, Stephen J.; Wang, Edward W.; Fereday, Sian; Traficante, Nadia; Salgia, Ravi; Werner, Theresa; Cohen, Adam L.; Moos, Philip; Chang, Jeffrey T.; Bowtell, David D. L.; Bild, Andrea H.
- Abstract
The evolution of resistance in high-grade serous ovarian cancer (HGSOC) cells following chemotherapy is only partially understood. To understand the selection of factors driving heterogeneity before and through adaptation to treatment, we profile single-cell RNA-sequencing (scRNA-seq) transcriptomes of HGSOC tumors collected longitudinally during therapy. We analyze scRNA-seq data from two independent patient cohorts to reveal that HGSOC is driven by three archetypal phenotypes, defined as oncogenic states that describe the majority of the transcriptome variation. Using a multi-task learning approach to identify the biological tasks of each archetype, we identify metabolism and proliferation, cellular defense response, and DNA repair signaling as consistent cell states found across patients. Our analysis demonstrates a shift in favor of the metabolism and proliferation archetype versus cellular defense response archetype in cancer cells that received multiple lines of treatment. While archetypes are not consistently associated with specific whole-genome driver mutations, they are closely associated with subclonal populations at the single-cell level, indicating that subclones within a tumor often specialize in unique biological tasks. Our study reveals the core archetypes found in progressive HGSOC and shows consistent enrichment of subclones with the metabolism and proliferation archetype as resistance is acquired to multiple lines of therapy. High-grade serous ovarian cancer (HGSOC) is prone to developing resistance to treatment. Here, the authors use single-cell RNA-seq and an analysis of archetypes, and find that shifts in metabolism and proliferation are associated with the response to treatment and clonal heterogeneity in HGSOC.
- Subjects
OVARIAN cancer; PHENOTYPES; DNA repair; RNA sequencing; SOMATIC mutation; ARCHETYPES
- Publication
Nature Communications, 2021, Vol 12, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-021-23171-3